CHI Health St. Francis Cancer Treatment Center oncologists Ryan Ramaekers, MD and David Crockett, MD were recently recognized with achievement awards from the National Cancer Institute (NCI). Dedication in conducting clinical trials, referring patients for prevention, screening and treatment, and providing high quality care earned each a NCI Community Oncology Research Program (NCORP) Certificate of Excellence. Dr. Ramaekers received a gold and Dr. Crockett a silver–both for patient enrollments in NCI treatment and cancer control trials from August 2018 through April 2019.
The honors were announced in late August at the NCORP annual meeting in Bethesda, Md. St. Francis celebrated Nov. 13 with an awards luncheon at the hospital.
“This is not just my award, it's the whole team’s,” said Ramaekers.
NCORP is a national network that brings cancer clinical trials and care delivery studies to people in their own communities.
About Cancer Research and Clinical Trials at St. Francis
Through the Catholic Health Initiatives Institute for Research (CIRI) Oncology Research Alliance (CORA), CHI Health St. Francis Cancer Treatment Center is a member of the National Cancer Institute (NCI)’s Community Oncology Research Program (NCORP). Participation in the NCORP program allows St. Francis patients access to cancer prevention, control, screening, and post-treatment surveillance clinical trials conducted by NCORP and to NCI’s National Clinical Trials Network (NCTN) treatment, imaging and quality of life trials.
Participants in clinical trials play an active role in their own health care, gain access to new research treatments before they are widely available and help others by contributing to medical knowledge. St. Francis offers patients opportunities to participate in cancer trials, the best scientific thinking, the latest translation of national research into bedside practices, and state-of-the-art technology.
National Cancer Institute’s Community Oncology Research Program (NCORP)
The NCORP is a national network that brings cancer clinical trials and care delivery studies to people in their own communities. NCORP is comprised of 7 Research Bases and 46 Community Sites, 14 of which are designated as Minority/Underserved Community Sites. NCORP is committed to integrating health disparities research questions across all studies in the network. By bringing cancer clinical research studies to individuals in their own communities, the NCORP research reflects national diversity so the evidence generated contributes to improved patient outcomes and a reduction in cancer disparities for all people.
For more information about the NCORP program, visit ncorp.cancer.gov.